BIB 01 OF 34: ARMED FORCES REPORTABLE MEDICAL EVENTS Flashcards
1
Q
WHAT IS THE FULL BIB CONCERNING THE ARMED FORCES REPORTABLE MEDICAL EVENTS?
[FRONT]
A
AMRED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES - CASE DEFINITIONS (07-2017), ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES & CASE DEFINITIONS
2
Q
WHO PREPARED ARMED FORCES REPORTABLE MEDICAL EVENTS - GUIDELINES AND CASE DEFINITIONS?
[FRONT]
A
PREPARED IN COLLABORATION WITH: U.S. AIR FORCE SCHOOL OF AEROSPACE MEDICINE PUBLIC HEALTH CENTER NAVY AND MARINE CORPS PUBLIC HEALTH CENTER
3
Q
WHAT IS A REPORTABLE MEDICAL EVENT?
[FRONT]
A
A REPORTABLE MEDICAL EVENT MAY REPRESENT AN INHERENT SIGNIFICANT THREAT TO PUBLIC HEALTH AND MILITARY OPERATIONS.
4
Q
WHAT IS THE POSSIBLE IMPACT OF REPORTABLE MEDICAL EVENTS?
[FRONT]
A
THESE EVENTS HAVE THE POTENTIAL TO AFFECT LARGE NUMBERS OF PEOPLE, TO BE WIDELY TRANSMITTED WITHIN A POPULATION, TO HAVE SEVERE/LIFE THREATENING CLINICAL MANIFESTATIONS, AND TO DISRUPT MILITARY TRAINING AND DEPLOYMENT.
5
Q
WHAT CAN TIMELY ACCURATE REPORTING OF REPORTABLE MEDICAL EVENTS ENSURE?
[FRONT]
A
TIMELY, ACCURATE REPORTING OF PROBABLE, SUSPECTED OR CONFIRMED CASES ENSURES PROPER IDENTIFICATION, TREATMENT, CONTROL, ADN FOLLOW-UP OF CASES.
6
Q
WHAT ENTITIES CHOSE REPORTABLE MEDICAL EVENTS AND HOW WERE THEY CHOSEN?
[FRONT]
A
REPORTABLE MEDICAL EVENTS WERE CHOSEN BY CONSENSUS AND RECOMMENDATIONS FROM EACH OF THE SERVICES ABOUT NOTIFIABLE DISEASES FROM THE CENTERS FOR DISEASE CONTROL (CDC), THE COUNCIL OF STATE AND TERRITORIAL EPIDEMIOLOGISTS (CSTE), AND EVENTS THAT MILITARY PUBLIC HEALTH EXPERTS HAVE IDENTIFIED AS REPRESENTING SIGNIFICANT MILITARY THREATS THAT DESERVE ADDITIONAL EMPHASIS FOR SURVEILLANCE.
7
Q
WHAT ARE THE PRINCIPAL GOALS OF THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT?
[FRONT]
A
THE PRINCIPAL GOALS OF THIS DOCUMENT ARE TO ACHIEVE DATA CONSISTENCY AND STANDARDIZATION OF REPORTABLE EVENTS TRACKING ACROSS EACH SERVICE AND TO AID LOCAL-LEVEL REPORTING BY PROVIDING PROGRAMMATIC GUIDANCE.
8
Q
IN AN ONGOING EFFORT TO CONSOLIDATE DOD MEDICAL SURVEILLANCE DATA, HOW MANY SECTIONS ARE INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
EIGHT
9
Q
WHAT IS THE FIRST SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(1) REQUIREMENT TO REPORT
10
Q
WHAT IS THE SECOND SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(2) REQUIREMENT TO REPORT
11
Q
WHAT IS THE THIRD SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(3) COMMON DELINEATION FOR REPORTABLE MEDICAL EVENTS
12
Q
WHAT IS THE FOURTH SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(4) WHAT NOT TO REPORT
13
Q
WHAT IS THE FIFTH SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(5) SERVICE POINTS OF CONTACT
14
Q
WHAT IS THE SIXTH SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(6) REPORTABLE MEDICAL EVENT CASE DEFINITIONS
15
Q
WHAT IS THE SEVENTH SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(7) REPORTABLE DISEASE ICD-10 CODES & SYNONYMS
16
Q
WHAT IS THE EIGHTH SECTION INCLUDED IN THE ARMED FORCES REPORTABLE MEDICAL EVENTS GUIDELINES AND CASE DEFINITIONS DOCUMENT?
[FRONT]
A
(8) REFERENCES
17
Q
WHY HAS THE REPORTING OF IMPORTANT PREVENTABLE MEDICAL EVENTS BEEN A CORNERSTONE OF PUBLIC HEALTH SURVEILLANCE?
[FRONT]
A
REPORTING OF REPORTABLE MEDICAL EVENTS IS IS ROOTED IN THE INTERNATIONAL AND NATIONAL REGULATIONS TO PREVENT THE INTRODUCTION, TRANSMISSION, AND SPREAD OF COMMUNICABLE DISEASES.
18
Q
WHAT DOCUMENT REQUIRES THE REPORTING OF MEDICAL EVENTS WITHIN THE DoD AS DEFINED IN THIS GUIDE?
[FRONT]
A
DODD 6490.02E
19
Q
WHAT DOCUMENT SPECIFIES THE PROCESS BY WHICH THESE REQUIREMENTS ARE IMPLEMENTED WITHIN EACH COMPONENT?
[FRONT]
A
SPECIFIC SERVICE AND COCOM GUIDANCE
20
Q
HOW MANY REFERENCES ARE WERE USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
A
TEN
21
Q
WHAT IS THE FIRST REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
A
(1) DODD 6490.02E “COMPREHENSIVE HEALTH SURVEILLANCE”
22
Q
WHAT IS THE SECOND REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
A
(2) DODI 6490.03 “DEPLOYMENT HEALTH”
23
Q
WHAT IS THE THIRD REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
A
(3) JOINT PUBLICATION 4-02 “DOCTRINE FOR HELATH SERVICE SUPPORT FOR JOINT OPERATIONS”
24
Q
WHAT IS THE FOURTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
A
(4) CJCS MEMORANDUM MCM 0028-07 “PROCEDURES FOR DEPLOYMENT HEALTH SURVEILLANCE”
25
WHAT IS THE FIFTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(5) NAVY MANUAL OF THE MEDICAL DEPARTMENT P-117 ARTICLES 2-17 AND 2-19
26
WHAT IS THE SIXTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(6) BUMED INST 6220.12 SERIES “MEDICAL SURVEILLANCE AND MEDICAL EVENT REPORTING”
27
WHAT IS THE SEVENTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(7) ARMY REGULATIONS 40-5 “MEDICAL SERVICES PREVENTIVE MEDICINE”
28
WHAT IS THE EIGHTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(8) DEPARTMENT OF THE ARMY PAMPHLET 40-11 “MEDICAL SERVICES PREVENTIVE MEDICINE”
29
WHAT IS THE NINTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(9) AFI 48-105 “SURVEILLANCE, PREVENTION, AND CONTROL OF DISEASES AND CONDITIONS OF PUBLIC HEALTH OR MILITARY SIGNIFICANCE”
30
WHAT IS THE TENTH REFERENCE DOCUMENT USED TO DETERMINE THE REQUIREMENT TO REPORT?
[FRONT]
(10) COAST GUARD MEDICAL MANUAL COMDINST M6000.1F “CHAPTER 7, PREVENTIVE MEDICINE”
31
WHAT ENTITY MAY REQUIRE REPORTING OF ADDITIONAL DISEASES AND CONDITIONS?
[FRONT]
INDIVIDUAL SERVICES
32
WHAT DOCUMENTS ARE TO BE REFERENCED WHEN INVESTIGATING DETAILS FOR THE REPORTING OF ADDITIONAL DISEASES AND CONDITIONS?
[FRONT]
SERVICE-SPECIFIC INSTRUCTIONS
33
WHAT ENTITY MAY BE REQUIRED TO REPORT ADDITIONAL DISEASES AND EVENTS TO THEIR RESPECTIVE COUNTRY, STATE, AND/OR LOCAL HEALTH DEPARTMENT?
[FRONT]
MILITARY MEDICAL DEPARTMENTS
34
IN WHAT WOULD MILITARY MEDICAL DEPARTMENTS LOOK FOR REFERENCE AS TO REPORTING ADDITIONAL DISEASES PER THE COUNTRY IN WHICH THEY ARE CURRENTLY OPERATING?
[FRONT]
REFER TO THE STATUS OF FORCES AGREEMENTS, THE DIRECTIVES LISTED ABOVE AND RESPECTIVE STATE HEALTH DEPARTMENT REGULATIONS FOR DETAILS.
35
HOW MANY “CRITERION ITEMS” ARE USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
EIGHT
36
WHAT IS THE FIRST LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(1) IS THERE A CLEAR CASE DEFINITION?
37
WHAT IS THE SECOND LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(2) ARE THERE CONTROL AND/OR PREVENTION MEASURES THAT CAN BE PUT INTO PLACE OR NEED TO BE TRACKED WITHIN THE DOD?
38
WHAT IS THE THIRD LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(3) IS REPORTING OF THE EVENT THE ONLY SUFFICIENT, TIMELY SOURCE OF THE NECESSARY INFORMATION?
39
WHAT IS THE FOURTH LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(4) DOES IT REPRESENT AN INHERENT, SIGNIFICANT THREAT TO MILITARY PUBLIC HEALTH?
40
WHAT IS THE FIFTH LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(5) DOES IT REPRESENT A SIGNIFICANT MILITARY OPERATIONAL THREAT?
41
WHAT IS THE SIXTH LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(6) DOES IT HAVE THE POTENTIAL TO INFORM MILITARY PROGRAM GUIDANCE OR POLICY?
42
WHAT IS THE SEVENTH LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(7) IS THE TACTICAL BURDEN OF REPORTING WORTH THE TIME AND EFFORT?
43
WHAT IS THE EIGHTH LISTED CRITERIA ITEM USED COLLECTIVELY TO DECIDE WHETHER A MEDICAL DIAGNOSIS OR CONDITION SHOULD BE REPORTABLE OR NOT?
[FRONT]
(8) IS THE EVENT COMMONLY REPORTABLE BY STATE OR FEDERAL LAWS, REGULATIONS, OR GUIDELINES?
44
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF CASE DEFINITION?
[FRONT]
CASE DEFINITION. IN THIS GUIDE, A CASE DEFINITION REPRESENTS THE SPECIAL CLINICAL, LABORATORY, AND OTHER CRITERIA THAT MUST BE MET FOR A DISEASE OR CONDITION TO BE REPORTABLE.
45
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF REPORTABLE MEDICAL EVENT (RME)?
[FRONT]
REPORTABLE MEDICAL EVENT (RME). A MEDICAL EVENT OR CONDITION MANDATORY FOR REPORTING.
46
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF MEDICAL EVENT REPORT (MER)?
[FRONT]
MEDICAL EVENT REPORT (MER). THE ACTUAL REPORT CONTAINING INFORMATION FROM THE RME THAT IS PHYSICALLY ENTERED INTO THE DISEASE REPORTING SYSTEM INTERNET (DRSi).
47
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF BACKGROUND?
[FRONT]
BACKGROUND. THIS SECTION OF THE CASE DEFINITION PROVIDES DESCRIPTIVE INFORMATION ABOUT THE RME. THE BACKGROUND INCLUDES INFORMATION ABOUT THE CAUSATIVE AGENT, TRAVEL RISKS, AND CLINICAL DESCRIPTION.
48
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF CASE CLASSIFICATION?
[FRONT]
CASE CLASSIFICATION. A CASE CLASSIFICATION SPECIFIES WHAT IS NEEDED TO MEET THE CASE DEFINITION OF A REPORTABLE EVENT. A CASE DEFINITION CAN BE GROUPED INTO THREE CLASSIFICATION CATEGORIES: SUSPECTED, PROBABLE, OR CONFIRMED (FIGURE 1). EACH CASE CLASSIFICATION HAS IT’S OWN SPECIFIC SET OF CLINICAL AND/OR LABORATORY CRITERIA. NOT ALL RME’S HAVE ALL THREE CASE CLASSIFICATIONS.
49
IN CASE CLASSIFICATION, WHAT ARE THE TWO ELEMENTS OF “SUSPECTED CLASSIFICATION?”
[FRONT]
- EARLY IDENTIFICATION OF THE DISEASE IS CRITICAL FOR DISEASE CONTROL
- CASE DEFINITION USUALLY LIMIED TO CLINICAL SYMPTOMS WITHOUT LAB RESULTS
50
IN CASE CLASSIFICATION, WHAT ARE THE TWO ELEMENTS OF “PROBABLE CLASSIFICATION?”
[FRONT]
- CASE DEFINITION IS USUALLY MORE DETAILED THAN SUSPECTED CLASSIFICATION
- DOES NOT HAVE ALL THE REQUIRED ELEMENTS FOR CONFIRMED CASE
51
IN CASE CLASSIFICATION, WHAT ARE THE TWO ELEMENTS OF “CONFIRMED CLASSIFICATION?”
[FRONT]
- CASE DEFINITION IS THE MOST SPECIFIC
| - USUALLY REQUIRES LABORATORY SUPPORT
52
WHEN AND HOW SHOULD RME’S BE REPORTED?
[FRONT]
RME’S SHOULD BE REPORTED AT THE EARLIEST CASE CLASSIFICATION REQUIRED AND UPDATED REGULARLY AS MORE CLINICAL AND/OR LABORATORY INFORMATION BECOMES AVAILABLE.
53
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF CLINICAL DESCRIPTION?
[FRONT]
CLINICAL DESCRIPTION. A BRIEF DESCRIPTION OF CLINICAL SIGNS AND SYMPTOMS. UNLESS THE CLINICAL DESCRIPTION IS EXPLICITLY REFERENCED IN THE CASE CLASSIFICATION SECTION OF THE CASE DEFINITION, IT IS INCLUDED ONLY AS BACKGROUND INFORMATION.
54
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF EPIDEMIOLOGICALLY LINKED (EPI-LINK)?
[FRONT]
EPIDEMIOLOGICALLY LINKED (EPI-LINK). A CASE IN WHICH THE PATIENT: (A) HAD CONTACT WITH A CONFIRMED OR PROBABLE CASE, AS DEFINED BY THE CASE DEFINITION OR (B) WAS EXPOSED TO THE SAME SOURCE OF INFECTION AS A PROBABLE OR CONFIRMED CASE OR (C) IS A MEMBER OF A RISK GROUP AS DEFINED BY PUBLIC HEALTH DURING AN OUTBREAK.
55
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF CRITICAL REPORTING ELEMENTS?
[FRONT]
CRITICAL REPORTING ELEMENTS. ADDITIONAL INFORMATION IS SOMETIMES REQUIRED FOR SPECIFIC MERS. ENSURE THE INFORMATION LISTED IN THE REQUIRED COMMENTS SECTION OF THE CASE DEFINITION IS RECORDED IN THE MER. IF THE INFORMATION IS UNAVAILABLE, INDICATE SO.
56
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE DEFINITION OF INCIDENT RULE?
[FRONT]
INCIDENT RULE. ONLY INCIDENT CASES ARE REPORTABLE. INCIDENT CASES ARE NEWLY DIAGNOSED CASES IN A PERSON REGARDLESS OF HOW LONG THE PERSON HAS BEEN SICK.
57
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS NOT TO BE REPORTED?
[FRONT]
- HIV IS NOT REPORTABLE THROUGH DRSi.
- HEALTHCARE-ASSOCIATED INFECTIONS. REPORT HEALTHCARE ASSOCIATED INFECTIONS TO YOUR INFECTION. CONTROL PRACTITIONER (ICP).
- PREVALENT CASES. DRSi IS A REPORTING TOOL FOR INCIDENT CASES ONLY.
58
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES CIA STAND FOR?
[FRONT]
CIA - CHEMILUMINESCENCE IMMUNOASSAY
59
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES CF STAND FOR?
[FRONT]
COMPLEMENT FIXATION
60
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES CSF STAND FOR?
[FRONT]
CEREBROSPINAL FLUID
61
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES DA STAND FOR?
[FRONT]
DIRECT AGGLUTINATION
62
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES DFA STAND FOR?
[FRONT]
DIRECT IMMUNOFLUORESCENT ANTIBODY
63
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES DNA STAND FOR?
[FRONT]
DEOXYRIBONUCLEIC ACID
64
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES ELISA STAND FOR?
[FRONT]
ENZYME LINKED IMMUNOSORBENT ASSAY
65
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES EIA STAND FOR?
[FRONT]
ENZYME IMMUNOASSAY
66
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES FTA-ABS STAND FOR?
[FRONT]
FLUORESCENT TREPONEMAL ANTIBODY ABSORPTION
67
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES HI STAND FOR?
[FRONT]
HEMAGGLUTINATION INHIBITION
68
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IFA STAND FOR?
[FRONT]
INDIRECT IMMUNOFLUORESCENT ANTIBODY
69
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IgG STAND FOR?
[FRONT]
IMMUNOGLOBULIN ANTIBODY CLASS G
70
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IgM STAND FOR?
[FRONT]
IMMUNOGLOBULIN ANTIBODY CLASS M
71
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IHA STAND FOR?
[FRONT]
INDIRECT HEMAGGLUTINATION
72
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IHC STAND FOR?
[FRONT]
IMMUNOHISTOCHEMISTRY
73
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES IU/L STAND FOR?
[FRONT]
INTERNATIONAL UNITS PER LITER
74
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES LA STAND FOR?
[FRONT]
LATEX AGGLUTINATION
75
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES LRN STAND FOR?
[FRONT]
LABORATORY RESPONSE NETWORK
76
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES MAT STAND FOR?
[FRONT]
MICROAGGLUTINATION TEST
77
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES NAAT STAND FOR?
[FRONT]
NUCLEIC ACID AMPLIFICATION TEST
78
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES NAT STAND FOR?
[FRONT]
NUCLEIC ACID TEST
79
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES PCR STAND FOR?
[FRONT]
POLYMERASE CHAIN REACTION
80
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES PRNT STAND FOR?
[FRONT]
PLAQUE REDUCTION NEUTRALIZATION TEST
81
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES RNA STAND FOR?
[FRONT]
RIBONUCLEIC ACID
82
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES RPR STAND FOR?
[FRONT]
RAPID PLASMA REAGIN
83
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES SAT STAND FOR?
[FRONT]
SLIDE AGGLUTINATION TEST
84
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES TP-PA STAND FOR?
[FRONT]
TREPONEMA PALLIDUM PARTICLE AGGLUTINATION
85
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES WBC STAND FOR?
[FRONT]
WHITE BLOOD CELL
86
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT DOES VDRL STAND FOR?
[FRONT]
VENEREAL DISEASE RESEARCH LABORATORY
87
(1 OF 8) WHAT IS THE LINNAEAN NAME FOR AMEBIASIS?
[1]
Entamoeba histolytica
88
(2 of 8) WHAT IS THE CAUSATIVE AGENT FOR AMEBIASIS?
[1]
Entamoeba histolytica
89
(3 OF 8) WHAT ARE THE TRAVEL RISKS FOR AMEBIASIS?
[1]
PRESENT WORLDWIDE; PARTICULARLY IN PARTS OF AFRICA, ASIA, AND CENTRAL AND SOUTH AMERICA.
90
(4 OF 8) WHAT IS THE CLINICAL DESCRIPTION FOR AMEBIASIS?
[1]
AN ILLNESS CAUSED BY INFECTION OF THE LARGE INTESTINE THA TIS CHARACTERIZED BY SYMPTOMS RANGING FROM MILD, CHRONIC DIARRHEA TO SEVERE AND SUDDEN ONSET DIARRHEA CONTAINING MUCUS, BLOOD, OR BOTH. EXTRAINTESTINAL OR INVASIVE INFECTIONS CAN ALSO OCCUR AND MAY PRESENT AS AN ACUTE ABSCESS IN THE LIVER, LUNG, BRAIN OR OTHER ORGANS. A GRANULOMATOUS LESION IN THE INTESTINE MAY BE DISCOVERED ON RARE OCCASION.
91
(5 OF 8) CONCERNING AMEBIASIS, HOW IS PROBABLE CLASSIFICATION DEFINED?
[1]
PROBABLE:
A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
-MICROSCOPIC IDENTIFICATION OF E. hystolytica TROPHOZOITES WITH INGESTED RED BLOOD CELLS FROM STOOL OR,
-E. hystolytica POSITIVE ANTIBODY WITHOUT CLINICAL EVIDENCE OF EXTRAINTESTINAL OR INVASIVE AMEBIASIS
92
(6 OF 8) CONCERNING AMEBIASIS, HOW IS CONFIRMED CLASSIFICATION DEFINED?
[1]
CONFIRMED:
AN ASYMPTOMATIC CASE WITH ALL OF THE FOLLOWING:
-E. hystolytica NUCLEIC ACID (DNA) DETECTED (EXAMPLE: PCR, SEQUENCING) AND
-EPIDEMIOLOGICALLY LINKED TO A CONFIRMED CASE
OR
A CASE THA TMEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- E. histolytica NUCLEIC ACID (DNA) DETECTED (EXAMPLE: PCR, SEQUENCING) FROM ANY CLINICAL SPECIMEN OR
- E. histolytica POSITIVE ANTIGEN (EXAMPLE: EIA) FROM STOOL OR
- E. histolytica POSITIVE ANTIBODY WITH CLINICAL EVIDENCE OF EXTRAINTESTINAL OR INVASIVE AMEBIASIS (EXAMPLE: EIA, IHA) OR
- MICROSCOPIC IDENTIFICATION OF E. histolytica TROPHOZOITES FROM INTESTINAL TISSUE BIOPSIES, ULCER SCAPINGS, OR EXTRA-INTESTINAL TISSUE
93
(7 OF 8) CONCERNING AMEBIASIS, WHAT ARE THE CRITICAL REPORTING ELEMENTS?
[1]
- DOCUMENT THE ANATOMICAL SITE OF INFECTION.
| - DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURING WITHIN THE INCUBATION PERIOD.
94
(8 OF 8) CONCERNING AMEBIASIS, WHAT ARE THE LISTED COMMENTS?
[1]
MICROSCOPIC TEST FROM STOOL REPORTED AS POSITIVE FOR E. histolytica AND E. dispar SHOULD ONLY BE REPORTED AS PROBABLE IF TROPHOZOITES WITH INGESTED RED BLOOD CELLS ARE SEEN.
95
TEMP:
(1 OF 8) WHAT IS THE LINNAEAN NAME FOR AMEBIASIS?
(2 OF 8) WHAT IS THE CAUSATIVE AGENT FOR AMEBIASIS?
(3 OF 8) WHAT ARE THE TRAVEL RISKS FOR AMEBIASIS?
(4 OF 8) WHAT IS THE CLINICAL DESCRIPTION FOR AMEBIASIS?
(5 OF 8) CONCERNING AMEBIASIS, HOW IS PROBABLE CLASSIFICATION DEFINED?
(6 OF 8) CONCERNING AMEBIASIS, HOW IS CONFIRMED CLASSIFICATION DEFINED?
(7 OF 8) CONCERNING AMEBIASIS, WHAT ARE THE CRITICAL REPORTING ELEMENTS?
(8 OF 8) CONCERNING AMEBIASIS, WHAT ARE THE LISTED COMMENTS?
A
96
(1 OF 8) WHAT IS THE LINNAEAN NAME FOR ANTHRAX?
[2]
Bacillus anthracis
97
(2 OF 8) WHAT IS THE CAUSATIVE AGENT FOR ANTHRAX?
[2]
Bacillus anthracis
98
(3 OF 8) WHAT ARE THE TRAVEL RISKS FOR ANTHRAX?
[2]
MOST COMMON IN CENTRAL AND SOUTH AMERICA, SUB-SAHARAN AFRICA, CENTRAL AND SOUTHWESTERN ASIA, AND SOUTHERN AND EASTERN EUROPE
99
WHAT IS THE BASIC CLINICAL DESCRIPTION OF ANTHRAX?
[2]
AN ACCUTE ONSET ILLNESS WITH AT LEAST ONE OF THE FOLLOWING:
- AN ILLNESS WITH AT LEAST ONE SPECIFIC OR TWO NON-SPECIFIC SYMPTOMS AND SIGNS THAT ARE COMPATIBLE WITH CUTANEOUS, INGESTION, INHALATION, OR INJECTION ANTHRAX; SYSTEMIC INVOLVEMENT; OR ANTHRAX MENINGITIS OR
- A DEATH OF UNKNOWN CAUSE AND ORGAN INVOLVEMENT CONSISTENT WITH ANTHRAX
100
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW MANY DISTINCT CLINICAL FORMS OF ANTHRAX ARE LISTED?
[2]
FIVE
101
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FIRST DISTINCT CLINICAL FORM OF ANTHRAX LISTED?
[2]
CUTANEOUS: A PAINLESS SKIN LESION EVOLVING DURING A PERIOD OF 2-6 DAYS FROM A PAPULE, THROUGH A VESICULAR STATE, TO A DEPRESSED BLACK ESCHAR SURROUNDED BY EDEMA. FEVER, MALAISE, AND LYMPHADENOPATHY MAY ALSO BE PRESENT.
102
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE SECOND DISTINCT CLINICAL FORM OF ANTHRAX LISTED?
[2]
INHALATION: SYMPTOMS RESEMBLING A VIRAL RESPIRATORY ILLNESS, FOLLOWED BY HYPOXIA, DYSPNEA, OR ACUTE RESPIRATORY DISTRESS WITH RESULTING CYANOSIS AND SHOCK. RADIOGRAPHIC EVIDENCE OF MEDIASTINAL WIDENING OR PLEURAL EFFUSION IS COMMON IN LATER STAGES OF ILLNESS.
103
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE THIRD DISTINCT CLINICAL FORM OF ANTHRAX LISTED?
[2]
INJECTION: SEVERE SOFT TISSUE INFECTION THAT APPEARS LIKE A SIGNIFICANT EDEMA OR BRUISING AFTER AN INJECTION. NO ESCHAR OR PAIN IS ASSOCIATED. SYMPTOMS MAY ALSO INCLUDE FEVER, SHORTNESS OF BREATH, OR NAUSEA.
104
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FOURTH DISTINCT CLINICAL FORM OF ANTHRAX LISTED?
[2]
INGESTION: PRESENTS AS TWO SUBTYPES
- GASTROINTESTINAL: SEVERE ABDOMINAL PAIN AN TENDERNESS, NAUSEA, VOMITING OR VOMITING OF BLOOD, BLOODY DIARRHEA, FEVER, ABDOMINAL SWELLING, LOSS OF APPETITE, AND POSSIBLY SEPTICEMIA.
- OROPHARYNGEAL: A PAINLESS MUCOSAL LESION IN THE ORAL CAVITY OR OROPHARYNX WITH PHARYNGITIS, SWOLLEN LYMPH NODES IN THE NECK, EDEMA, FEVER, AND POSSIBLY SEPTICEMIA.
105
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FIFTH DISTINCT CLINICAL FORM OF ANTHRAX LISTED?
[2]
MENINGEAL: MAY COMPLICATE ANY FORM OF ANTHRAX OR MAY BE A PRIMARY MANIFESTATION. SYMPTOMS INCLUDE FEVER, HEADACHE (OFTEN SEVER), NAUSEA, VOMITING, FATIGUE, MENINGEAL SIGNS, ALTERED MENTAL STATUS, AND OTHER NEUROLOGICAL SIGNS SUCH AS SEIZURES OR FOCAL SIGNS ARE USUALLY PRESENT. MOST PATIENTS WITH ANTHRAX MENINGITIS HAVE CEREBRAL SPINAL FLUID ABNORMALITIES CONSISTENT WITH BACTERIAL MENINGITIS.
106
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ANTHRAX, HOW DOES A SUSPECTED CASE CLASSIFICATION PRESENT?
[2]
SUSPECTED: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE, WHERE A TEST HAS BEEN ORDERED BUT RESULTS ARE NOT AVAILABLE YET, AND THERE IS NO EPIDEMIOLOGIC EVIDENCE OF ANTHRAX.
107
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ANTHRAX, HOW DOES A PROBABLE CASE CLASSIFICATION PRESENT?
[2]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- EPIDEMIOLOGICALLY LINKED TO A DOCUMENTED ANTHRAX ENVIRONMENTAL EXPOSURE OR
- GRAM STAIN DEMONSTRATING GRAM-POSITIVE RODS, SQUARE-ENDED, IN PAIRS OR SHORT CHAINS OR
- POSITIVE RESULT ON A TEST WITH ESTABLISHED PERFORMANCE IN A CLIA-ACCREDITED LABORATORY
108
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ANTHRAX, HOW DOES A CONFIRMED CASE CLASSIFICATION PRESENT?
[2]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WIHT ANY OF THE FOLLOWING:
- B. anthracis IDENTIFIED BY CULTURE BY AN LRN REFERENCE LABORATORY FROM ANY CLINICAL SPECIMEN OR
- HISTOPATHOLOGIC IDENTIFICATION OF B. anthracis ANTIGENS FROM TISSUE SAMPLES BY IHC USING BOTH B. anthracis CELL WALL AND CAPSULE MONOCLONAL ANTIBODIES OR
- AT LEAST A FOUR-FOLD INCREASE OF B. anthracis IgG ANTIBODIES AGAINST PROTECTIVE ANTIGEN BETWEEN ACUTE AND CONVALESCENT SERA USING CDC’S QUANTITATIVE ANTI-PA IgG ELISA TEST OR
- AT LEAST A FOUR-FOLD CHANGE OF B. anthracis IgG ANTIBODIES AGAINST PROTECTIVE ANTIGEN IN PAIRED CONVALESCENT SERA USING CDC’S QUANTITATIVE ANTI-PA IgG ELISA TEST OR
- DETECTION OF LETHA FACTOR (LF) IN CLINICAL SERUM SPECIMENS BY LF MASS SPECTROMETRY OR
- B. anthracis NUCLEIC ACID (DNA) DETECTED BY LRN-VALIDATED PCR, BIOFIRE’S JBAIDS ANTHRAX DETECTION KIT FOR PX01 AND PX02, OR OTHER DOD APPROVED TEST FROM NORMALLY STERILE SITE (EXAMPLE: BLOOD OR CSF OR, LESS COMMONLY, JOINT, PLEURAL, OR PERICARDIAL FLUID) OR A LESION OF AFFECTED TISSUE.
109
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ANTHRAX, WHAT ARE THE CRITICAL REPORTING ELEMENTS?
[2]
- SPECIFY THE CLINICAL FORM(S) OF THE DISEASE.
- DOCUMENT THE ANATOMICAL SITE OF INFECTION.
- DOCUMENT THE SOURCE OF INFECTION IF KNOWN.
- NOTE THE PATIENT’S ANTHRAX IMMUNIZATION HISTORY.
110
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ANTHRAX, WHAT ARE THE LISTED COMMENTS ON ANTHRAX?
[2]
COMMENTS: *EPIDEMIOLOGIC LINKAGE INCLUDES:
- EXPOSURE TO ENVIRONMENT, FOOD, ANIMAL, MATERIALS, OR OBJECTS THAT IS SUSPECT OR CONFIRMED TO BE CONTAMINATED WITH B. anthracis.
- EXPOSURE TO THE SAME ENVIRONMENT, FOOD, ANIMAL, MATERIALS, OR OBJECTS AS ANOTHER PERSON WHO HAS LABORATORY-CONFIRMED ANTHRAX;
- CONSUMPTION OF THE SAME FOOD AS ANOTHER PERSON WHO HAS LABORATORY-CONFIRMED ANTHRAX
111
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, CONCERNING ARBOVIRAL DISEASES, HOW IS THE NAME LISTED?
[3]
ARBOVIRAL DISEASES, NEUROINVASIVE AND NON-NEUROINVASIVE.
112
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS INCLUDED UNDER THE NAME ARBOVIRAL DISEASES?
[3]
INCLUDES: WEST NILE FEVER, WEST NILE ENCEPHALITIS, JAPANESE ENCEPHALITIS, AND OTHER MOSQUITO-BORNE VIRUSES (WESTERN EQUINE ENCEPHALITIS, EASTERN EQUINE ENCEPHALITIS, ST. LOUIS ENCEPHALITIS, CALIFORNIA VIRUS ENCEPHALITIS), TICK-BORNE VIRUSES (POWASSAN VIRUS, TICK-BORN ENCEPHALITIS), AND OTHERS.
113
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS EXCLUDED UNDER THE NAME ARBOVIRAL DISEASES?
[3]
EXCLUDES: CHICKUNGUNYA VIRUS DISEASE, DENGUE VIRUS INFECTIONS, LYME DISEASE, RELAPSING FEVER, RIFT VALLEY FEVER, SPOTTED FEVER RICKETTSIOSES, YELLOW FEVER VIRUS, AND ZIKA VIRUS. (SEE RESPECTIVE CASE DEFINITIONS)
114
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENTS FOR ARBOVIRAL DISEASES?
[3]
CAUSATIVE AGENT: VARIOUS ARBOVIRUSES
115
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE TRAVEL RISKS FOR ARBOVIRAL DISEASES?
[3]
TRAVEL RISKS: PRESENT WORLDWIDE
116
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW MANY CLINICAL DESCRIPTIONS ARE THERE FOR ARBOVIRAL DISEASES?
[3]
THE CLINICAL DESCRIPTION LISTS ARBOVIRAL DISEASES AS AN ILLNESS THAT RANGES FROM MILD FEBRILE ILLNESS TO SEVERE ENCEPHALITIS CATEGORIZED INTO TWO CLINICAL PRESENTATIONS.
117
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FIRST CLINICAL PRESENTATION LISTED FOR ARBOVIRAL DISEASES?
[3]
NON-NEUROINVASIVE DISEASE:
- FEVER(CHILLS) AS REPORTED BY THE PATIENT OR A HEALTH-CARE PROVIDER AND
- ABSENCE OF NERUOINVASIVE DISEASE AND
- ABSENCE OF A MORE LIKELY CLINICAL EXPLANATION. OTHER CLINICALLY COMPATIBLE SYMPTOMS OF ARBOVIRUS DISEASE INCLUDE: HEADACHE, MYALGIA, RASH, ARTHRALGIA, VERTIGO, VOMITING, PARESIS AND/OR NUCHAL RIGIDITY.
118
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE SECOND CLINICAL PRESENTATION LISTED FOR ARBOVIRAL DISEASES?
[3]
NEUROINVASIVE DISEASE:
- MENINGITIS, ENCEPHALITIS, ACUTE FLACCID PARALYSIS, OR OTHER ACUTE SIGNS OF CENTRAL OR PERIPHERAL NEUROLOGICAL DYSFUNCTION, AS DOCUMENTED BY A PHYSICIAN AND
- ABSENCE OF A MORE LIKELY CLINICAL EXPLANATION. OTHER CLINICALLY COMPATIBLE SYMPTOMS OF ARBOVIRUS DISEASE INCLUDE: HEADACHE, MYALGIA, RASH, ARTHRALGIA, VERTIGO, VOMITING, PARESIS AND/OR NUCHAL RIGIDITY.
119
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION LISTED FOR NON-NEUROINVASIVE ARBOVIRAL DISEASES?
[3]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF NON-NEUROINVASIVE DISEASE AS DESCRIBED ABOVE WITH VIRUS-SPECIFIC POSITIVE IgM ANTIBODY FROM SERUM AND NO OTHER LABORATORY TEST PERFORMED.
120
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION LISTED FOR NON-NEUROINVASIVE ARBOVIRAL DISEASES?
[3]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF NON-NEUROINVASIVE DISEASE AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- VIRUS IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN EXCEPT CSF OR
- VIRUS-SPECIFIC POSITIVE ANTIGEN FROM ANY CLINICAL SPECIMEN EXCEPT CSF OR
- VIRUS-SPECIFIC NUCLEIC ACID (RNA) DETECTED (EXAMPLE: PCR, SEQUENCING, NAAT) FROM ANY CLINICAL SPECIMEN EXCEPT CSF OR
- AT LEAST A FOUR-FOLD CHANGE OF VIRUS-SPECIFIC ANTIBODY TITERS BETWEEN ACUTE AND CONVALESCENT SERA OR
- VIRUS-SPECIFIC POSITIVE IgM ANTIBODY FROM SERUM FOLLOWED BY CONFIRMATORY VIRUS-SPECIFIC POSTIVE NEUTRALIZING ANTIBODY (EXAMPLE: PRNT) IN THE SAME OR LATER SERUM SPECIMEN.
121
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION LISTED FOR NEUROINVASIVE ARBOVIRAL DISEASES?
[3]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF NEUROINVASIVE DISEASE AS DESCRIBED ABOVE WITH VIRUS-SPECIFIC POSITIVE IgM ANTIBODY FROM CSF OR SERUM AND NO OTHER LABORATORY TEST PERFORMED.
122
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION LISTED FOR NEUROINVASIVE ARBOVIRAL DISEASES?
[3]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- VIRUS IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN OR
- VIRUS-SPECIFIC POSITIVE ANTIGEN FROM ANY CLINICAL SPECIMEN OR
- VIRUS-SPECIFIC NUCLEIC ACID (RNA) DETECTED (EXAMPLE: PCR, SEQUENCING, NAAT) FROM ANY CLINICAL SPECIMEN OR
- AT LEAST A FOUR-FOLD CHANGE OF VIRUS-SPECIFIC ANTIBODY TITERS BETWEEN ACUTE AND CONVALESCENT SERA OR
- VIRUS-SPECIFIC POSITIVE IgM ANTIBODY FOLLOWED BY CONFIRMATORY VIRUS-SPECIFIC POSITIVE NEUTRALIZING ANTIBODY (EXAMPLE: PRNT) FROM SERUM IN THE SAME OR A LATER SPECIMEN
- VIRUS-SPECIFIC POSITIVE IgM ANTIBODY FROM CSF AND A NEGATIVE IgM ANTIBODY IN CSF FOR OTHER ARBOVIRUSES ENDEMIC TO THE REGION WHERE EXPOSURE OCCURED.
123
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS LISTED FOR ARBOVIRAL DISEASES?
[3]
CRITICAL REPORTING ELEMENTS:
- SPECIFY THE ETIOLOGIC/CAUSATIVE AGENT.
- DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURRING WITHIN THE INCUBATION PERIOD.
- DOCUMENT THE CIRCUMSTANCES UNDER WHICH THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES, ENVIRONMENTAL EXPOSURES, OR OTHER HIGH RISK ACTIVITIES.
- NOTE THE PATIENT’S DISEASE SPECIFIC IMMUNIZATION HISTORY.
124
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE “SECONDARY NAME” LISTED FOR BOTULISM?
[4]
BOTULISM (Clostridium botulinum toxin)
125
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED CAUSATIVE AGENT FOR BOTULISM?
[4]
CAUSATIVE AGENT: Clostridium botulinum TOXIN
126
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS?
[4]
TRAVEL RISKS: N/A
127
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW MANY CLINICAL DESCRIPTIONS ARE LISTED FOR BOTULISM?
[4]
BOTULISM IS CATEGORIZED INTO FOUR CLINICAL MANIFESTATIONS
128
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FIRST CLINICAL MANIFESTATION FOR BOTULISM?
[4]
FOODBORNE: AN ILLNESS OF VARIABLE SEVERITY. COMMON SYMPTOMS ARE DIPLOPIA, BLURRED VISION, AND BULBAR WEAKNESS. SYMMETRIC PARALYSIS MAY PROGRESS RAPIDLY.
129
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE SECOND CLINICAL MANIFESTATION FOR BOTULISM?
[4]
INFANT: AN ILLNESS OF INFANTS AGED LESS THAN 1 YEAR, CHARACTERIZED BY CONSTIPATION, POOR FEEDING, AND “FAILURE TO THRIVE” THAT MAY BE FOLLOWED BY PROGRESSIVE WEAKNESS, IMPAIRED RESPIRATION, AND DEATH.
130
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE THIRD CLINICAL MANIFESTATION FOR BOTULISM?
[4]
WOUND: AN ILLNESS RESULTING FROM TOXIN PRODUCED BY CLOSTRIDIUM BOTULINUM THAT HAS INFECTED A WOUND. COMMON SYMPTOMS ARE DIPLOPIA, BLURRED VISION, AND BULBAR WEAKNESS. SYMMETRIC PARALYSIS MAY PROGRESS RAPIDLY.
131
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FOURTH CLINICAL MANIFESTATION FOR BOTULISM?
[4]
OTHER: AN ILLNESS OF VARIABLE SEVERITY THAT OCCURES AMONG PERSONS GREATER THAN 1 YEAR OF AGE. COMMON SYMPTOMS ARE DIPLOPIA, BLURRED VISION, AND BULBAR WEAKNESS. SYMMETRIC PARALYSIS MAY PROGRESS RAPIDLY.
132
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A PROBABLE CASE CLASSIFICATION FOR FOODBORNE BOTULISM?
[4]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF FOODBORNE BOTULISM AS DESCRIBED ABOVE THAT IS EPIDEMIOLOGICALLY LINKED TO A FOOD SOURCE (EXAMPLE: INGESTION OF A HOME-CANNED FOOD WITHIN THE PREVIOUS 48 HOURS)
133
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A CONFIRMED CASE CLASSIFICATION FOR FOODBORNE BOTULISM?
[4]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF FOODBORNE BOTULISM AS DECRIBED ABOVE WITH ANY OF THE FOLLOWING:
- A HISTORY OF EATING THE SAME FOOD AS A LABORATORY CONFIRMED CASE
- C. botulinum TOXIN DETECTED IN SERUM, STOOL, OR PATIENT’S FOOD OR
- TOXIN PRODUCING C. botulinum IDENTIFIED BY CULTURE FROM STOOL
134
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A CONFIRMED CASE CLASSIFICATION FOR INFANT BOTULISM?
[4]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF INFANT BOTULISM AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- C. botulinum TOXIN DETECTED IN SERUM OR STOOL OR
- TOXIN PRODUCING C. botulinum IDENTIFIED BY CULTURE FROM STOOL
135
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A PROBABLE CASE CLASSIFICATION FOR WOUND BOTULISM?
[4]
PROBABLE: A CASE THAT MEETS CLINICAL DESCRIPTION OF WOUND BOTULISM AS DESCRIBED ABOVE IN A PATIENT WHO HAS NO SUSPECTED EXPOSURE TO CONTAMINATED FOOD AND WHO HAS ANY OF THE FOLLOWING:
- A HISTORY OF A FRESH, CONTAMINATED WOUND DURING THE 2 WEEKS BEFORE ONSET OF SYMPTOMS OR
- A HISTORY OF INJECTION DRUG USE WITHIN 2 WEEKS BEFORE ONSET OF SYMPTOMS
136
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A CONFIRMED CASE CLASSIFICATION FOR WOUND BOTULISM?
[4]
CONFIRMED: A CASE THAT MEETS ALL OF THE FOLLOWING:
-MEETS THE CLINICAL DESCRIPTION OF WOUND BOTULISM AS DESCRIBED ABOVE IN A PATIENT WHO HAS NO SUSPECTED EXPOSURE TO CONTAMINATED FOOD AND WHO HAS ANY OF THE FOLLOWING EXPOSURES: (I). A HISTORY OF A FRESH, CONTAMINATED WOUND DURING THE 2 WEEKS BEFORE ONSET OF SYMPTOMS OR
(II). A HISTORY OF INJECTION DRUG USE WITHIN THE 2 WEEKS BEFORE ONSET FO SYMPTOMS AND
-ANY OF THE FOLLOWING: (I). C. botulinum TOXIN DETECTED IN SERUM OR (II). TOXIN PRODUCING C. botulinum IDENTIFIED BY CULTURE FROM A WOUND.
137
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DESCRIPTION FOR A CONFIRMED CASE CLASSIFICATION FOR OTHER BOTULISM?
[4]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF OTHER BOTULISM AS DESCRIBED ABOVE WITHOUT A HISTORY OF INGESTION OF SUSPECT FOOD AND HAS NO WOUNDS, AND WHO HAS ANY OF THE FOLLOWING:
- C. botulinum TOXIN DETECTED IN ANY CLINICAL SPECIMEN OR
- TOXIN PRODUCING C. botulinum IDENTIFIED BY CULTURE FORM ANY CLINICAL SPECIMEN
138
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED CRITICAL REPORTING ELEMENTS FOR BOTULISM?
[4]
- SPECIFY THE CLINICAL FORM OF THE DISEASE.
| - DOCUMENT THE SOURCE OF INFECTION IF KNOWN.
139
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULL LISTED NAME FOR BRUCELLOSIS?
[5]
BRUCELLOSIS (Brucella species)
140
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR BRUCELLOSIS?
[5]
CAUSATIVE AGENT: BRUCELLA SPECIES
141
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR BRUCELLOSIS?
[5]
TRAVEL RISKS: PRESENT WORLDWIDE
142
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED CLINICAL DESCRIPTION FOR BRUCELLOSIS?
[5]
CLINICAL DESCRIPTION: AN ACUTE SYSTEMIC DISEASE CHARACTERIZED BY FEVER PLUS ANY OF THE FOLLOWING: NIGHT SWEATS, ARTHRALGIA, HEADACHE, FATIGUE, ANOREXIA, MYALGIA, WEIGHT LOSS, ARTHRITIS, SPONDYLITIS, MENINGITIS, OR FOCAL ORAGAN INVOLVEMENT (ENDOCARDITIS, ORCHITIS, EPIDIDYMITIS, HEPATOMEGALY, SPLENOMEGALY)
143
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DEFINITION OF A PROBABLE CASE CLASSIFICATION FOR BRUCELLOSIS?
[5]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- EPIDEMIOLOGICALLY LINKED TO A CONFIRMED HUMAN OR ANIMAL CASE OR
- BRUCELLA TOTAL ANTIBODY TITER >= 1:160 BY SAT OR MAT FROM SERUM OR
- BRUCELLA NUCLEIC ACID (DNA) DETECTED BY PCR FROM ANY CLINICAL SPECIMEN
144
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED DEFINITION OF A CONFIRMED CASE CLASSIFICATION FOR BRUCELLOSIS?
[5]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- BRUCELLA IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN OR
- AT LEAST A FOUR-FOLD INCREASE OF BRUCELLA ANTIBODY TITER BETWEEN ACUTE AND CONVALESCENT SERA SEPARATED BY AT LEAST 2 WEEKS
145
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED CRITICAL REPORTING ELEMENTS FOR BRUCELLOSIS?
[5]
CRITICAL REPORTING ELEMENTS:
- DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURRING WIHTIN THE INCUBATION PERIOD
- DOCUMENT THE SOURCE FO INFECTION IF KNOWN
- DOCUMENT THE CIRCUMSTANCES UDNER WHICH THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES, ENVIRONMENTAL EXPOSURE, OR OTHER HIGH RISK ACTIVITIES.
146
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR BRUCELLOSIS?
[5]
COMMENTS: A POSITIVE BRUCELLA SLIDE AGGLUTINATION TEST IS THE SAME THING AS MAT; IT THEREFORE MEETS THE PROBABLE CASE DEFINITION AND SHOULD BE REPORTED.
147
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS THE NAME LISTED FOR CAMPYLOBACTRIOSIS?
[6]
CAMPYLOBACTERIOSIS (Campylobacter species)
148
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CAMPYLOBACTERIOSIS?
[6]
CAUSATIVE AGENT: CAMPYLOBACTER BACTERIA SPECIES
149
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR CAMPYLOBACTERIOSIS?
[6]
TRAVEL RISK: PRESENT WORLDWIDE
150
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED CLINICAL DESCRIPTION FOR CAMPYLOBACTERIOSIS?
[6]
CLINICAL DESCRIPTION: AN ACUTE ENTERIC DISEASE CHARACTERIZED BY DIARRHEA, ABDOMINAL PAIN, NAUSEA, AND SOMETIMES VOMITING. SEVERE SYMPTOMS AND INVASIVE INFECTIONS OCCUR RARELY CAUSING BACTEREMIA, MENINGITIS OR OTHER FOCAL INFECTIONS.
151
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS A PROBABLE CASE CLASSIFICATION DEFINED FOR CAMPYLOBACTERIOSIS?
[6]
PROBABLE:
ANY OF THE FOLLOWING:
-CAMPYLOBACTER POSITIVE LABORATORY TEST BY A METHOD OTHER THAN CULTURE (EXAMPLE: EIA, PCR) OR
-A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE THAT IS EPIDEMIOLOGICALLY LINKED TO A PROBABLE OR A CONFIRMED CASE
152
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS A CONFIRMED CASE CLASSIFICATION DEFINED FOR CAMPYLOBACTERIOSIS?
[6]
CONFIRMED: CAMPYLOBACTER IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN
153
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR CAMPYLOBACTERIOSIS?
[6]
CRITICAL REPORTING ELEMENTS:
- DOCUMENT THE SPECIES IF KNOWN
- DOCUMENT THE SOURCE OF INFECTION IF KNOWN
- DOCUMENT RELEVANT TRAVEL AN DEPLOYMENT HISTORY OCCURRING WITHIN THE INCUBATION PERIOD.
- DOCUMENT THE CIRCUMSTANCES UNDER WHIHC THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES ENVIRONMENTAL EXPOSURES, OR OTHER HIGH RISK ACTIVITIES
- DOCUMENT IF THE CASE PATIENT WORKS IN, LIVES IN, OR ATTENDS A HIGH TRANSMISSION SETTING SUCH AS FOOD HANDLING, DAY CARE, SCHOOL, GROUP LIVING, HEALTHCARE, TRAINING CENTER, OR SHIP.
154
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR CAMPYLOBACTERIOSIS?
[6]
COMMENTS: NONE
155
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULL STATED NAME FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
CHIKUNGUNYA VIRUS DISEASE (CHKUNGUNYA VIRUS)
156
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
CAUSATIVE AGENT: CHIKUNGUNYA VIRUS
157
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED CLINICAL DESCRIPTION FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
CLINICAL DESCRIPTION: CHIKUNGUNYA TYPICALLY CAUSES NON-NEUROINVASIVE SYMPTOMS CAUSING HIGH FEVER (TYPICALLY > 102 DEGREES F [> 39 DEGREES C]), SEVERE ARTHRALGIA, ARTHRITIS, RASH, HEADACHE, CONJUNCTIVITIS, NAUSEA, VOMITING, AND LYMPHOPENIA. JOINT SYMPTOMS ARE USUALLY BILATERAL AND SYMMETRIC AND CAN BE SEVERE AND DEBILITATING. ACUTE SYMPTOMS TYPICALLY RESOLVE WITHIN 7 TO 10 DAYS.
158
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
PROBABLE: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ALL OF THE FOLLOWING:
- CHIKUNGUNYA POSITIVE IgM ANTIBODY FORM CSF OR SERUM AND
- NO OTHER LABORATORY TEST PERFORMED
159
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOV WITH ANY OF THE FOLLOWING:
- CHIKUNGUNYA IDENTIFIED BY CULTURE FROM TISSUE BLOOD, CSF, OR OTHER BODY FLUID OR
- CHIKUNGUNYA POSITIVE ANTIGEN FROM TISSUE, BLOOD, CSF, OR OTHER BODY FLUID OR
- CHIKUNGUNYA NUCLEIC ACID (RNA) DETECTED BY PCR FROM TISSUE, BLOOD, CSF, OR OTHER BODY FLUID OR
- AT LEST A FOUR-FOLD INCREASE OF ANTIBODY TITER BETWEEN ACUTE AND CONVALESCENT SERA OR
- CHKUNGUNYA POSITIVE IgM ANTIBOIDES FROM SERUM FOLLOWED BY CONFIRMATORY VIRUS-SPECIFIC NEUTRALIZING ANTIBODIES (EXAMPLE: PRNT) IN THE SAME OR LATER SPECIMEN
160
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
CRITICAL REPORTING ELEMENTS: DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURRING WITHIN THE INCUBATION PERIOD. DOCUMENT THE CIRCUMSTANCES UNDER WHICH THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES, ENVIRONMENTAL EXPOSURES, OR OTHER HIGH RISK ACTIVITIES.
161
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR CHIKUNGUNYA VIRUS DISEASE (CHIKUNGUNYA VIRUS)?
[7]
COMMENTS: NONE
162
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULL LISTED NAME FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
CHLAMYDIA TRACHOMATIS INFECTION (Chlamydia trachomatis)
163
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
Chlamydia trachomatis
164
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
TRAVEL RISKS: N/A
165
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CLINICAL DESCRIPTION FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
AN INFECTION CHARACTERIZED BY URETHRITIS, EPIDIDYMITIS, CERVICITIS, ACUTE SALPINGITIS, OR OTHER SYNDROMES WHEN SEXUALLY TRANSMITTED. INFECTIONS ARE OFTEN ASYMPTOMATIC IN WOMEN. PERINATAL INFECTIONS MAY RSULT IN INCLUSION CONJUNCTIVITIS AND PNEUMONIA IN NEWBORNS. OTHER SYNDROMES CAUED BY C. trachomatis INLUDE LYMPHOGRANULOMA VENEREUM AND TRACHOMA.
166
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS A CONFIRMED CASE CLASSIFICATION DEFINED FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
CONFIRMED CASE CLASSIFICATION: A CASE WITH ANY OF THE FOLLOWING:
- C. trachomatis IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN OR
- C. trachomatis POSITIVE ANTIGEN FROM ANY CLINICAL SPECIMEN OR
- C.trachomatis NUCLEIC ACID (DNA) DETECTED (EXAMPLE: PCR, SEQUENCING, NAAT, PROBE) FROM ANY CLINICAL SPECIMEN
167
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED CRITICAL REPORTING ELEMENTS FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
CRITICAL REPORTING ELEMENTS: NONE
168
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR CHLAMYDIA TRACHOMATIS INFECTION?
[8]
COMMENTS: REPORT CO-INFECTIONS WITH OTHER ORGANISMS, LIKE GONORRHEA, SEPARATELY AS INDIVIDUAL RMES.
169
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED FULL NAME FOR CHOLERA?
[9]
CHOLERA (Vibrio cholera O1 or 0139)
170
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CHOLERA?
[9]
CAUSATIVE AGENT: Vibrio cholera’s, serogroup O1 or 0139
171
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE TRAVEL RISKS LISTED FOR CHOLERA?
[9]
TRAVEL RISKS: PRESENT WORLDWIDE; PARTICULARLY IN SUB SAHARAN AFRICA, THE INDIAN SUBCONTINENT AND SOUTHEAST ASIA
172
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CLINICAL DESCRIPTION FOR CHOLERA?
[9]
CLINICAL DESCRIPTION: AN ACUTE ILLNESS CHARACTERIZED BY PROFUSE WATERY DIARRHEA AND VOMITING. SEVERITY IS VARIABLE; HOWEVER, SEVERE CASES CAN RESULT IN RAPID DEHYDRATION, ELECTROLYTE DISTURBANCES, AND DEATH.
173
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS A CONFIRMED CASE CLASSIFICATION DEFINED FOR CHOLERA?
[9]
CONFIRMED CASE CLASSIFICATION: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOE WITH ANY OF THE FOLLOWING:
- TOXIN PRODUCING V. cholera O1 OR 0139 IDENTIFIED BY CULTURE FROM STOOL OR
- V. cholerae O1 OR 0139 POSITIVE ANTIBODY FROM SERUM OR
- V. cholerae O1 OR 0139 NUCLEIC ACID (DNA) DETECTED (EXAMPLE: PCR, SEQUENCING, NAAT, PROBE) FROM STOOL OR VOMITUS
174
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR CHOLERA?
[9]
CRITICAL REPORTING ELEMENTS:
- SPECIFY THE SEROGROUP (V. cholerae O1 OR V. cholerae 0139) IF KNOWN
- DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURRING WITHIN THE INCUBATION PERIOD
175
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT COMMENTS ARE LISTED FOR CHOLERA?
[9]
COMMENTS: NONE
176
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED FULL NAME FOR COCCIDIOIDOMYCOSIS?
[10]
COCCIDIOIDOMYCOSIS (Coccidioides SPECIES)
177
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED COMMON NAME FOR COCCIDIOIDOMYCOSIS?
[10]
COMMON NAME: VALLEY FEVER
178
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT FEVER(S) ARE NOT INCLUDED UNDER COCCIDIOIDOMYCOSIS?
EXCLUDES: RIFT VALLEY FEVER (SEE RIFT VALLEY FEVER)
179
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR COCCIDIOIDOMYCOSIS?
[10]
CAUSATIVE AGENT: COCCIDIOIDES SPECIES
180
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE TRAVEL RISKS FOR COCCIDIOIDOMYCOSIS?
[10]
TRAVEL RISKS: MOST COMMON IN SOUTHWEST UNITED STATES, MEXICO, CENTRAL AND SOUTH AMERICA
181
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CLINICAL DESCRIPTION LISTED FOR COCCIDIOIDOMYCOSIS?
[10]
CLINICAL DESCRIPTION: AN ILLNESS CHARACTERIZED WITH AT LEAST ONE OF THE FOLLOWING: INFLUENZA-LIKE SYPTOMS (EXAMPLE: FEVER, CHEST PAIN, COUGH, MYALGIA, ARTHALGIA, AND HEADACHE), PNEUMONIA OR PULMONARY LESION, ERYTHEMA NODOSUM OR MULTIFORME RASH, INVOLVEMENT OF BONES, JOINTS, OR SKIN BY DISSEMINATION, MENINGITIS OR INVOLVEMENT OF THE VISCERA AND LYMPH NODES. INFECTION MAY DISSEMINATE TO MULTIPLE ORGAN SYSTEMS.
182
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION DEFINITION FOR COCCIDIOIDOMYCOSIS?
[10]
CONFIRMED CASE CLASSIFICATION: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- COCCIDIOIDAL POSITIVE IgM ANTIBODY BY IMMUNODIFFUSION, EIA, LATEX AGGLUTINATION, OR TUBE PRECIPITATION FROM ANY BODILY FLUID OR
- COCCIDIOIDAL POSITIVE IgG ANTIBODY BY EIA OR COMPLEMENT FIXATION FROM ANY BODILY FLUID OR
- COCCIDIOIDES IDENTIFIED BY CULTURE FROM ANY CLINICAL SPECIMEN OR
- HISTOPATHOLOGIC IDENTIFIED OF COCCIDIOIDES FROM TISSUE SAMPLE OR
- COCCIDIOIDAL SKIN-TEST CONVERSION FROM NEGATIVE TO POSITIVE AFTER ONSET OF CLINICAL SIGNS AND SYMPTOMS
183
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR COCCIDIOIDOMYCOSIS?
[10]
CRITICAL REPORTING ELEMENTS:
- DOCUMENT THE SOURCE OF INFECTION IF KNOWN
- DOCUMENT ANY RELEVANT TRAVEL AND DEPLOYMENT HISTORY WITHIN THE INCUBATION PERIOD
184
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED COMMENTS FOR COCCIDIOIDOMYCOSIS?
[10]
COMMENTS: NONE
185
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS INCLUDED IN THE DEFINITION FOR COLD WEATHER INJURIES?
[11]
INCLUDES: SERVICE MEMBER CASES ONLY
186
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR COLD WEATHER INJURIES?
[11]
CAUSATIVE AGENT: N/A
187
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE TRAVEL RISKS FOR COLD WEATHER INJURIES?
[11]
TRAVEL RISKS: N/A
188
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW MANY CLINICAL DESCRIPTIONS FOR COLD WEATHER INJURIES ARE THERE?
[11]
THREE.
189
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FIRST LISTED CLINICAL DESCRIPTION FOR COLD WEATHER INJURIES?
[11]
HYPOTHERMIA: REDUCTION OF BODY TEMPERATURE TO <= 95 DECREES F. IT CAN RESULT FROM EITHER DRY-LAND WHOLE BODY EXPOSURE TO COLD TEMPERATURES OR IMMERSION IN COLD WATER. FREEZING TERMPARATURES ARE NOT REQUIRED TO PRODUCE HYPOTHERMIA.
190
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE SECOND LISTED CLINICAL DESCRIPTION FOR COLD WEATHER INJURIES?
[11]
FREEZING PERIPHERAL INJURIES: FREEZING INJURIES (EXAMPLE: FROSTBITE) OCCUR ONLY WHEN EXPOSED TO TEMPERATURES BELOW FREEZING. THEY RESULT FROM THE FREEZING OF TISSUE FLUIDS IN THE SKIN AND/OR SUBCUTANEOUS TISSUE. ALTHOUGH IT HAS OFTEN BEEN CLASSIFED AS 1ST TO 4TH DEGREE LEVELS OF INJURY SEVERITY, FINAL CLASSIFICATION OFTEN TAKES WEEKS AND IS NOT HELPFUL FOR IMMEDIATE TREATMENT. A MORE RECENT CLASSIFICATION SYSTEM USES TWO LEVELS: SUPERFICIAL OR DEEP INJURIES. DO NOT DELAY REPORTING TO DETERMINE CLASSIFICATION.
191
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE THIRD LISTED CLINICAL DESCRIPTION FOR COLD WEATHER INJURIES?
[11]
NON-FREEZING PERIPHERAL INJURIES: A SPECTRUM OF LOCALIZED NON-FREEZING INJURIES, USUALLY OF EXTREMITIES (EXAMPLE: TRENCH FOOD, IMMERSION FOOD, CHILBLAINS), THAT OCCUR DUE TO PROLONGED VASOCONSTRICTION IN RESPONSE TO COLD THAT LEADS T O TISSUE INJURY ADN DESTRUCTION. THESE INJURIES DEVELOP OVER A PERIOD OF HOURS TO DAYS. THTEY MAY OCCUR AT TEMPERATURES BELOW OR ABOVE FREEZING AND CAN OCCUR AT TEMPERATURES AS HIGH AS 60 DEGREES F WITH PROLONGED EXPOSURE. INJURY IS ACCELERATED BY EXPOSURE TO DAMP CONTRADICTIONS. (NOTE: THE TERM “TRENCH FOOT” IS ALSO SOMETIMES USED TO DESCRIBE A TROPICAL FOOT INJURY OR “JUNGLE ROT.”)
192
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION FOR HYPOTHERMIA (UNDER COLD WEATHER INJURIES DEFINITION)?
[11]
HYPOTHERMIA:
PROBABLE: A CASE OF PROVIDER-DIAGNOSED HYPTHERMIA
193
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR HYPOTHERMIA (UNDER COLD WEATHER INJURIES DEFINITION)?
[11]
HYPOTHERMIA:
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF HYPOTHERMIA AS DESCRIBED ABOVE WITH A CORE BODY TEMPERATURE <= 95 DEGREES F OR <= 35 DEGREES C AS MEASURED BY RECTAL, ESOPHAGEAL, OR OTHER CENTRAL METHOD
194
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR FREEZING PERIPHERAL INJURIES (UNDER COLD WEATHER INJURIES DEFINITION)?
[11]
FREEZING PERIPHERAL INJURIES:
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF FREEZING PERIPHERAL INJURIES AS DESCRIBED ABOVE OCCURRING FROM EXPOSURE TO TEMPERATURES BELOW FREEZING WHER ETHE EXTENT OF THE FREEZING INJURY CAN BE CLASSIFIED AS:
-SUPERFICIAL: PARIAL OR FULL THICKNESS FREEZING OF THE EPIDERMIS WITHOUT INVOLVEMENT OF THE UNDERLYING TISSUE. MOBILITY IS UNAFFECTED, AND BLISTERING MAY OCCUR OR
-DEEP: FULL THICKNESS FREEZING OF THE EPIDERMIS ACCOMPANIED BY FEEZING OF SUBCUTANEOUS TISSUE AND WHICH MAY INVOLVE MUSCLES, TENDONS, AND BONES AS SEVERITY INCREASES OR
-UNKNOWN: AS YET UNCLASSIFIED
195
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR NON-FREEZING PERIPHERAL INJURIES (UNDER COLD WEATHER INJURIES DEFINITION)?
[11]
NON-FREEZING PERIPHERAL INJURIES:
CONFIRMED: A CASE THAT MEETS THE CLINICAL DESCRIPTION OF NON-FREEZING PERIPHERAL INJURIES AS DESCRIBED ABOVE OCCURRING FROM EXPOSURE TO A COLD AN WET OR DAMP ENVIRONMENT.
196
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS LISTED FOR COLD WEATHER INJURIES?
[11]
CRITICAL REPORTING ELEMENTS:
- SPECIFY THE TYPE OF INJURY
- DOCUMENT THE ANATOMICAL SITE OF INJURY
- DOCUMENT THE CIRCUMSTANCES UNDER WHICH THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES, ENVIRONMENTAL EXPOSURES, OR OTHER HIGH RISK ACTIVITIES.
197
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE COMMENTS LISTED FOR COLD WEATHER INJURIES?
[11]
PLEASE SPECIFY AMBIENT TEMPERATURE IF KNOWN IN DEGREES FAHRENHEIT (ESTIMATE IF UNKNOWN)
198
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULL NAME LISTED FOR CRYPTOSPORIDIOSIS?
[12]
CRYPTOSPORIDIOSIS (Cryptosporidium species)
199
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CRYPTOSPORIDIOSIS?
[12]
CAUSATIVE AGENT: Cryptosporidium species
200
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR CRYPTOSPORIDIOSIS?
[12]
TRAVEL RISKS: N/A
201
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CLINICAL DESCRIPTION FOR CRYPTOSPORIDIOSIS?
[12]
CLINICAL DESCRIPTION: AN ILLNESS CHRACTERIZED BY DIARRHEA AND ANY OF THE FOLLOWING: DURATION OF DIARRHEA OF 72 HOURS OR MORE, ABDOMINAL CRAMPING, VOMITING, OR ANOREXIA.
202
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION FOR CRYPTOSPORIDIOSIS?
[12]
PROBABLE: A CASE WITH ANY OF THE FOLLOWING:
- CRYPTOSPORIDIUM POSITIVE ANTIGEN BY A SCREENING TEST (EXAMPLE: IMMUNOCHROMATOGRAPHIC LATERAL FLOW TEST, RAPID CARD TEST) OR
- CRYPTOSPORIDIUM POSITIVE LABORATORY TEST OF UNKNOWN METHOD OR
- A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE THAT IS EPIDEMIOLOGICALLY LINKED TO A CONFIRMED CASE
203
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR CRYPTOSPORIDIOSIS?
[12]
CONFIRMED: A CASE WITH ANY OF THE FOLLOWING:
- CRYPTOSPORIDIUM POSITIVE ANTIGEN FROM ANY CLINICAL SPECIMEN OR
- CRYPTOSPORIDIUM NUCLEIC ACID (DNA) DETECTED BY PCR FROM ANY CLINICAL SPECIMEN OR
- MICROSCOPIC IDENTIFICATION OF CRYPTOSPORIDIUM FROM ANY CLINICAL SPECIMEN
204
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS CLASSIFICATION FOR CRYPTOSPORIDIOSIS?
[12]
CRITICAL REPORTING ELEMENTS:
- DOCUMENT THE SOURCE OF INFECTION IF KNOWN
- DOCUMENT THE CIRCUMSTANCES UNDER WHICH THE CASE PATIENT WAS EXPOSED INCLUDING DUTY EXPOSURE, OCCUPATIONAL ACTIVITIES, ENVIRONMENTAL EXPOSURES, OR OTHER HIGH RISK ACTIVITIES.
- DOCUMENT IF THE CASE PATIENT WORKS IN, LIVES IN, OR ATTENDS A HIGH TRANSMISSION SETTING SUCH AS FOOD HANDLING, DAY CARE, SCHOOL, GROUP LIVING, HEALTHCARE, TRAINING CENTER, OR SHIP
205
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR CRYPTOSPORIDIOSIS?
[12]
COMMENTS: NONE
206
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE LISTED NAME FOR CYCLOSPORIASIS?
[12]
CYCLOSPORIASIS (Cyclospora cayentanensis)
207
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR CYCLOSPORIASIS?
[12]
CAUSATIVE AGENT: Cyclospora cayetanensis
208
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR CYCLOSPORIASIS?
[12]
TRAVEL RISKS: MOST COMMON IN TROPICAL OR SUBTROPICAL REGIONS
209
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CLINICAL DESCRIPTION FOR CYCLOSPORIASIS?
[12]
CLINICAL DESCRIPTION: THE MOST COMMON SYMPTOM IS WATERY DIARRHEA WITH FREQUENT BOWEL MOVEMENTS. OTHER COMMON SYMPTOMS INCLUDE LOSS OF APPETITE WEIGHT LOSS, ABDOMINAL CRAMPS/BLOATING, NAUSEA, BODY ACHES, AND FATIGUE. VOMITING AND LOW GRAD FEVER ALSO MAY BE NOTED.
210
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE PROBABLE CASE CLASSIFICATION FOR CYCLOSPORIASIS?
[12]
PROBABLE CASE CLASSIFICATION: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE THAT IS EPIDEMIOLOGICALLY LINKED TO A CONFIRMED CASE.
211
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CONFIRMED CASE CLASSIFICATION FOR CYCLOSPORIASIS?
[12]
CONFIRMED CASE CLASSIFICATION: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- C. cayetanensis NUCLEIC ACID (DNA) DETECTED (EXAMPLE: PCR, SEQUENCING, NAAT) FROM STOOL, INTESTINAL FLUID/ASPIRATE OR INTESTINAL BIOPSY SPECIMENS OR
- MICROSCOPIC IDENTIFICATION OF C. cayetanensis FROM STOOL, INTESTINAL FLUID/ASPIRATE OR INTESTINAL BIOPSY SPECIMENS
212
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR CYCLOSPORIASIS?
[12]
CRITICAL REPORTING ELEMENTS:
- DOCUMENT THE SOURCE OF THE INFECTION IF KNOWN
- DOCUMENT IF THE CASE PATIENT WORKS IN, LIVES, OR ATTENDS A HIGH TRANSMISSION SETTING SUCH AS FOOD HANDLING, DAY CARE, SCHOOL, GROUP LIVING, HEALTHCARE, TRAINING CENTER, OR SHIP.
213
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR CYCLOSPORIASIS?
[12]
COMMENTS: NONE
214
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULLY LISTED NAME FOR DENGUE VIRUS INFECTION?
[13]
DENGUE VIRUS INFECTION (dengue virus -1, -2, -3, and -4)
215
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE CAUSATIVE AGENT FOR DENGUE VIRUS INFECTION?
[13]
CAUSATIVE AGENT: DENGUE VIRUS (DENV -1, -2, -3, AND -4)
216
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED TRAVEL RISKS FOR DENGUE VIRUS INFECTION?
[13]
TRAVEL RISKS: MOST COMMON IN TROPICAL AND SUBTROPICAL AREAS OF SOUTH AMERICA, AFRICA, AND ASIA, MEXICO, AND OCEANA TO INCLUDE THE PACIFIC AND THE CARIBBEAN.
217
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULLY LISTED CLINICAL DESCRIPTION FOR DENGUE VIRUS INFECTION?
[13]
CLINICAL DESCRIPTION: AN ACUTE FEBRILE ILLNESS TYPICALLY PRESENTING WITH AT LEAST ONE OF THE FOLLOWING: NAUSEA, VOMITING, RASH, ACHES AND PAINS, TOURNIQUET TEST POSITIVE OR LEUKOPENIA. SEVERE MANIFESTATIONS (SEVERE PLASMA LEAKAGE, SEVERE BLEEDING FROM THE GASTROINTESTINAL TRACT OR VAGINA, OR SEVERE ORGAN INVOLVEMENT) ARE RARE, BUT MAY BE FATAL.
218
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS THE PROBABLE CASE CLASSIFICATION DEFINED FOR DENGUE VIRUS INFECTION?
[13]
PROBABLE CASE CLASSIFICATION: A CASE THAT MEETS THE CLINICAL DESCRIPTION AS DESCRIBED ABOVE WITH:
-DENGUE POSITIVE IgM ANTIBODY FROM SERUM OR CSF IN A PERSON WHO HAS: (1) DOCUMENTED OR UNKNOWN EXPOSURE TO OTHER FLAVIVIRUSES (EXAMPLE: YELLOW FEVER VIRUS, JAPANESE ENECEPHALITIS VIRUS, WEST NILE VIRUS) OR (2) RECENT RECEIPT OF A FLAVIVIRUS JVACCINE
219
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, HOW IS THE CONFIRMED CASE CLASSIFICATION DEFINED FOR DENGUE VIRUS INFECTION?
[13]
CONFIRMED CASE CLASSIFICATION: A CASE THAT MEETS ANY OF THE CLINICAL CASE DEFINITIONS AS DESCRIBED ABOVE WITH ANY OF THE FOLLOWING:
- DENGUE NUCLEIC ACID (RNA) DETECTED BY PCR FROM ANY CLINICAL SPECIMEN OR
- DENGUE POSITIVE ANTIGEN BY DFA, IFA, OR IHC FROM TISSUE OR
- DENGUE NS1 POSITIVE ANTIGEN FROM SERUM OR PLASMA OR
- DENGUE IDENTIFIED BY CULTURE FROM SERUM, PLASMA OR CSF OR
- DENGUE POSITIVE IgM ANTIBODY FROM SERUM OR CSF IN A PERSON WHO HAS HAD NO DOCUMENTED EXPOSURE TO OTHER FLAVIVIRUSES (EXAMPLE: YELLOW FEVER VIRUS, JAPANESE ENECEPHALITIS VIRUS, WEST NILE VIRUS) OR RECENT RECEIPT OF A FLAVIVIRUS VACCINE OR
- SEROCONVERSION FROM A NEGATIVE IgG FOLLOWED BY A POSTIVE IgG OR
- AT LEAST A FOUR-FOLD INCREASE OF ANTIBODY TITER BETWEEN ACUTE AND CONVALESCENT SERA SEPARATED BY AT LEAST 2 WEEKS FOLLOWED BY A CONFIRMATORY NEUTRALIZATION TEST (EXAMPLE: PRNT) THAT HAS A GERATER THAN FOUR-FOLD HIGHER END POINT TITER AS COMPARED TO THE OTHER FLAVIVIRUS TESTED WITH IT
220
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE CRITICAL REPORTING ELEMENTS FOR DENGUE VIRUS INFECTION?
[13]
CRITICAL REPORTING ELEMENTS:
- SPECIFY SEROTYPE IF KNOWN
- DOCUMENT RELEVANT TRAVEL AND DEPLOYMENT HISTORY OCCURRING WITHIN THE INCUBATION PERIOD
221
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT ARE THE LISTED COMMENTS FOR DENGUE VIRUS INFECTION?
[13]
COMMENTS: NONE
222
ACCORDING TO THE ARMED FORCES REPORTABLE MEDICAL EVENTS DOCUMENT, WHAT IS THE FULL NAME LISTED FOR DIPTHERIA?
[14]
DIPTHERIA (Corynebacterium diphtheriae)
